Literature DB >> 24107383

Fine needle aspiration cytology of benign salivary gland tumors with myoepithelial cell participation: an institutional experience of 575 cases.

Soomin Ahn1, Yuil Kim, Young Lyun Oh.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the diagnostic accuracy of fine needle aspiration (FNA) cytology of benign salivary gland tumors with myoepithelial cell participation, namely, pleomorphic adenoma, basal cell adenoma and myoepithelioma, at a single institution over a period of 10 years. STUDY
DESIGN: This study was based on 575 cytologic and matching histological samples (534 pleomorphic adenomas, 26 basal cell adenomas and 15 myoepitheliomas).
RESULTS: In most cases (393/534) of pleomorphic adenoma, a precise diagnosis was given. However, only 2 cases of basal cell adenoma and 1 case of myoepithelioma were diagnosed definitively. Descriptive diagnosis, instead of a definite diagnosis, was rendered in 16.9% of pleomorphic adenomas, 53.8% of basal cell adenomas and 40.0% of myoepitheliomas. Among all cases, the possibility of malignancy was raised in 5.2% of pleomorphic adenomas, 15.4% of basal cell adenomas and 20.0% of myoepitheliomas with a variable degree of suspicion.
CONCLUSION: In some cases, the distinction between these three neoplasms remains difficult in that all exhibit some degree of myoepithelial participation. However, FNA showed a high diagnostic accuracy in diagnosing benign salivary tumors with myoepithelial differentiation, and triage into this category provides sufficient information for clinicians to make treatment decisions.

Entities:  

Mesh:

Year:  2013        PMID: 24107383     DOI: 10.1159/000354958

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  7 in total

1.  A case of matrix-producing metaplastic carcinoma of the breast exhibiting similarities to pleomorphic adenoma on fine-needle aspiration cytology.

Authors:  Shogo Tajima; Kenji Koda; Yumie Ishii; Satoshi Hasegawa; Hidetarou Yokoyama
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification.

Authors:  Christopher C Griffith; Reetesh K Pai; Frank Schneider; Umamaheswar Duvvuri; Robert L Ferris; Jonas T Johnson; Raja R Seethala
Journal:  Am J Clin Pathol       Date:  2015-06       Impact factor: 2.493

3.  Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel.

Authors:  Daniel N Johnson; Mine Onenerk; Jeffrey F Krane; Esther Diana Rossi; Zubair Baloch; Güliz Barkan; Massimo Bongiovanni; Fabiano Callegari; Sule Canberk; Glen Dixon; Andrew Field; Christopher C Griffith; Nirag Jhala; Sara Jiang; Daniel Kurtycz; Lester Layfield; Oscar Lin; Zahra Maleki; Miguel Perez-Machado; Marc Pusztaszeri; Philippe Vielh; He Wang; Matthew A Zarka; William C Faquin
Journal:  Cancer Cytopathol       Date:  2020-04-08       Impact factor: 5.284

4.  Milan System for Reporting Salivary Gland Cytopathology: An Experience with the Implication for Risk of Malignancy.

Authors:  Chayanika Kala; Sanjay Kala; Lubna Khan
Journal:  J Cytol       Date:  2019 Jul-Sep       Impact factor: 1.000

5.  Mélange of Lymphoepithelial Lesions of Salivary Glands from a Tertiary Care Center of North East India: Diagnostic Conundrums.

Authors:  Zachariah Chowdhury; Vandana Raphael; Yookarin Khonglah; Jaya Mishra; Evarisalin Marbaniang; Biswajit Dey
Journal:  J Lab Physicians       Date:  2021-07-12

6.  The value of fine needle aspiration cytology in the clinical management of rare salivary gland tumors.

Authors:  Tibor Mezei; Simona Mocan; Alina Ormenisan; Beáta Baróti; Alina Iacob
Journal:  J Appl Oral Sci       Date:  2018-02-22       Impact factor: 2.698

7.  Evaluation of Accuracy of Milan System for Reporting Salivary Gland Cytology: Review of Morphology and Diagnostic Challenges in Each Category.

Authors:  K Amita; H B Rakshitha; Avinash Singh; S Vijay Shankar
Journal:  J Cytol       Date:  2019-12-23       Impact factor: 1.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.